| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10156682 | Biochemical and Biophysical Research Communications | 2018 | 7 Pages |
Abstract
This study demonstrates Activin A-p38 MAPK signaling pathway in leiomyoma and myometrium may contribute to excessive ECM production, leiomyoma growth and progression. Targeting Activin A-p38 MAPK signaling pathway could be a potential therapeutic intervention for uterine leiomyoma.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Huiqiong Bao, Thomas K. Sin, Guohua Zhang,